$2m boost to translate cancer research from lab to patient

University of Queensland researchers have received $2 million from the National Health and Medical Research Council to improve understanding of prostate and breast cancer and expedite the translation of research outcomes. 

The Development Grants scheme funds early-stage health and medical projects with a clear path to commercialisation and strong potential for intellectual property. 

NHMRC Development Grants recipients:  

Professor Gregory Monteith – improve a leading therapy for the treatment of advanced and refractory prostate cancer.  

Associate Professor David Muller – develop needle-free mRNA vaccines for the protection from and treatment of HER2+ breast cancer.